Genetic engineering is moving faster than almost any other scientific field. New tools now allow researchers to edit DNA with ...

Discover how prime editing is redefining the future of medicine by offering highly precise, safe, and versatile DNA corrections, bringing hope for more effective treatments for genetic diseases while ...

In recent years, the U.S. Food and Drug Administration has approved more than a dozen gene-editing and cell-based therapies. We are now in the second great wave of the genetic revolution, not defined ...

The Food and Drug Administration’s approval of nearly a dozen gene therapies in the past year, including milestone treatments for sickle cell disease and hemophilia B, has finally ushered in the era ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.

Eli Lilly (NYSE:LLY) agreed to acquire Orna Therapeutics in a deal valued at up to US$2.4b, expanding into in vivo cell and ...

Genetic testing is essential for targeted therapies and assessing familial cancer risks in GU cancers. The NIAGARA study indicates improved bladder cancer outcomes with chemotherapy and immunotherapy.

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...

Creation of a comprehensive genetic representation for more than 2.5 billion people across the Middle East and South Asia could make a major contribution towards advancing precision medicine. Creation ...